Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.23.1
Segment Information (Tables)
9 Months Ended
Oct. 01, 2022
Segment Reporting [Abstract]  
Schedule of Segment Information

The following tables present our segment information for the 13 weeks and 39 weeks ended October 1, 2022 and October 2, 2021 (in $000's):

 

 

 

Thirteen Weeks Ended

 

 

Thirty-Nine Weeks Ended

 

 

 

October 1, 2022

 

 

October 2, 2021

 

 

October 1, 2022

 

 

October 2, 2021

 

 

 

(As restated)

 

 

 

 

 

(As restated)

 

 

 

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

 

$

 

 

$

 

Recycling

 

 

8,587

 

 

 

12,113

 

 

 

28,449

 

 

 

29,391

 

Discontinued operations

 

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$

8,587

 

 

$

12,113

 

 

$

28,449

 

 

$

29,391

 

Gross profit

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

 

$

 

 

$

 

Recycling

 

 

1,034

 

 

 

3,081

 

 

 

4,536

 

 

 

6,245

 

Discontinued operations

 

 

 

 

 

 

 

 

 

 

 

 

Total Gross profit

 

$

1,034

 

 

$

3,081

 

 

$

4,536

 

 

$

6,245

 

Operating Income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

21

 

 

$

(182

)

 

$

(331

)

 

$

(1,232

)

Recycling

 

 

(1,845

)

 

 

274

 

 

 

(3,838

)

 

 

(1,753

)

Operating loss from continuing operations

 

 

(1,824

)

 

 

92

 

 

 

(4,169

)

 

 

(2,985

)

Discontinued operations

 

 

(1

)

 

 

(936

)

 

 

10,234

 

 

 

(2,820

)

Total Operating income (loss)

 

$

(1,825

)

 

$

(844

)

 

$

6,065

 

 

$

(5,805

)

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

 

$

 

 

$

 

Recycling

 

 

77

 

 

 

109

 

 

 

345

 

 

 

327

 

Discontinued operations

 

 

 

 

 

937

 

 

 

2

 

 

 

2,809

 

Total Depreciation and amortization

 

$

77

 

 

$

1,046

 

 

$

347

 

 

$

3,136

 

Interest (income) expense, net

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

 

$

 

 

$

 

Recycling

 

 

(130

)

 

 

125

 

 

 

123

 

 

 

323

 

Discontinued operations

 

 

 

 

 

 

 

 

 

 

 

 

Total Interest (income) expense, net

 

$

(130

)

 

$

125

 

 

$

123

 

 

$

323

 

Net income (loss) before benefit from income taxes

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

21

 

 

$

(182

)

 

$

(331

)

 

$

(1,232

)

Recycling

 

 

(1,985

)

 

 

208

 

 

 

(1,776

)

 

 

(1,145

)

Net loss before benefit from income taxes

 

 

(1,964

)

 

 

26

 

 

 

(2,107

)

 

 

(2,377

)

Discontinued operations

 

 

(1

)

 

 

(961

)

 

 

10,234

 

 

 

(2,832

)

Total Net income (loss) before benefit from income taxes

 

$

(1,965

)

 

$

(935

)

 

$

8,127

 

 

$

(5,209

)

 

 

 

 

As of
October 1,
2022

 

 

As of
January 1,
2022

 

Assets

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

Recycling

 

 

29,584

 

 

 

15,058

 

Discontinued operations

 

 

 

 

 

107

 

Total Assets

 

$

29,584

 

 

$

15,165

 

 

 

 

 

 

 

 

Intangible assets

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

Recycling

 

 

328

 

 

 

268

 

Discontinued operations

 

 

 

 

 

 

Total Intangible assets

 

$

328

 

 

$

268